Cassava Sciences: Fine Trading Stock, Terrible Investment

| Stock Market News, Stock Advice & Trading Tips     •     October 11, 2021, 2:11 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SAVA stock has fallen sharply in recent weeks. However, it's still a rather expensive bet on a controversial drug heading into Phase 3…
| Stock Market News, Stock Advice & Trading Tips     •     October 11, 2021, 2:33 pm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Protagonist Therapeutics (PTGX) stock is rocketing higher on Monday thanks to an update from the FDA concerning rusfertide clinical…

Comments

Popular posts from this blog

FSR Stock Climbs as Fisker Deliveries Jump 300% in Q4

BIRK Stock Alert: Goldman Sachs Is Pounding the Table on Birkenstock

InMed Pharmaceuticals (INM) Stock Soars 32% on R&D Updates